Literature DB >> 17147984

Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS.

Hao Cheng1, Zhongfa Liu, William Blum, John C Byrd, Rebecca Klisovic, Michael R Grever, Guido Marcucci, Kenneth K Chan.   

Abstract

A specific and sensitive HPLC-MS/MS method for the quantitative determination of valproic acid (VPA) and its metabolite, 2-propyl-4-pentenoic acid in human plasma has been developed, using VPA-d15 as the internal standard. The method was based on pre-column derivatization using 4-dimethylaminobenzylamine dihydrochloride. The derivatives were separated with a gradient elution and quantified by positive electrospray ionization with multiple reaction monitoring. The assay provides routine quantification limits of 200 ng/mL for VPA and 20 ng/mL for 4-ene VPA with within- and between-day coefficients of variation of <10%. This method has been applied to the analysis of plasma samples obtained from patients treated with this drug.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17147984     DOI: 10.1016/j.jchromb.2006.11.027

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.

Authors:  Juseop Kang; Yoo-Sin Park; Shin-Hee Kim; Sang-Hyun Kim; Min-Young Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-04-30       Impact factor: 2.016

2.  Comparison of LC-MS/MS vs chemiluminescent microparticle immunoassay in measuring the valproic acid concentration in plasma of epilepsy patients in a new perspective.

Authors:  Zhipeng Wang; Yunlei Yun; Xinfang Xie; Chunhua You; Haijun Miao; Feng Zhang; Shouhong Gao; Wansheng Chen
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

3.  Synergistic effect of MoS2 and diamond nanoparticles in electrochemical sensors: determination of the anticonvulsant drug valproic acid.

Authors:  María Dolores Petit-Domínguez; Carmen Quintana; Luis Vázquez; María Del Pozo; Isabel Cuadrado; Ana María Parra-Alfambra; Elena Casero
Journal:  Mikrochim Acta       Date:  2018-06-22       Impact factor: 5.833

4.  Use of TLC-Densitometric Method for Determination of Valproic Acid in Capsules.

Authors:  Wioletta Parys; Alina Pyka-Pająk
Journal:  Molecules       Date:  2022-01-24       Impact factor: 4.411

5.  HPLC-UV and GC-MS Methods for Determination of Chlorambucil and Valproic Acid in Plasma for Further Exploring a New Combined Therapy of Chronic Lymphocytic Leukemia.

Authors:  Katarzyna Lipska; Anna Gumieniczek; Rafał Pietraś; Agata A Filip
Journal:  Molecules       Date:  2021-05-13       Impact factor: 4.411

6.  Determination of valproic acid in human plasma using dispersive liquid-liquid microextraction followed by gas chromatography-flame ionization detection.

Authors:  Rana Fazeli-Bakhtiyari; Vahid Panahi-Azar; Mohammad Hossein Sorouraddin; Abolghasem Jouyban
Journal:  Iran J Basic Med Sci       Date:  2015-10       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.